IIM
AUPH icon

Ironwood Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Ironwood Investment Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Sell
113,066
-1,554
-1% -$22.7K 0.7% 44
2025
Q4 		$1.83M Sell
114,620
-238
-0.2% -$3.37K 0.77% 36
2025
Q3 		$1.27M Sell
114,858
-1,007
-0.9% -$11K 0.55% 61
2025
Q2 		$981K Sell
115,865
-1,779
-2% -$14.3K 0.48% 68
2025
Q1 		$946K Buy
117,644
+23,334
+25% +$189K 0.52% 63
2024
Q4 		$847K Buy
94,310
+1,129
+1% +$9.21K 0.42% 81
2024
Q3 		$683K Buy
93,181
+3,319
+4% +$20.6K 0.33% 85
2024
Q2 		$513K Sell
89,862
-3,317
-4% -$17.5K 0.27% 99
2024
Q1 		$467K Sell
93,179
-2,170
-2% -$14.7K 0.23% 107
2023
Q4 		$857K Sell
95,349
-641
-0.7% -$5.28K 0.45% 67
2023
Q3 		$746K Sell
95,990
-2,467
-3% -$24.1K 0.46% 65
2023
Q2 		$953K Sell
98,457
-1,240
-1% -$12.9K 0.55% 56
2023
Q1 		$1.09M Buy
99,697
+6,039
+6% +$53.2K 0.68% 51
2022
Q4 		$405K Sell
93,658
-36,652
-28% -$213K 0.27% 111
2022
Q3 		$980K Sell
130,310
-2,845
-2% -$24.6K 0.69% 51
2022
Q2 		$1.34M Buy
133,155
+38
+0% +$425 0.89% 32
2022
Q1 		$1.65M Buy
133,117
+1,357
+1% +$21K 0.9% 32
2021
Q4 		$3.01M Sell
131,760
-36,129
-22% -$856K 1.49% 14
2021
Q3 		$3.71M Sell
167,889
-429
-0.3% -$6.81K 1.93% 9
2021
Q2 		$2.18M Sell
168,318
-1,998
-1% -$25.5K 1.1% 21
2021
Q1 		$2.21M Buy
170,316
+27,238
+19% +$395K 1.17% 20
2020
Q4 		$1.98M Sell
143,078
-2,522
-2% -$36.7K 1.16% 20
2020
Q3 		$2.15M Sell
145,600
-180
-0.1% -$2.61K 1.53% 11
2020
Q2 		$2.37M Sell
145,780
-917
-0.6% -$14.7K 1.85% 7
2020
Q1 		$2.13M Sell
146,697
-6,292
-4% -$111K 2.13% 5
2019
Q4 		$3.1M Sell
152,989
-9,971
-6% -$91.8K 2.14% 8
2019
Q3 		$870K Sell
162,960
-500
-0.3% -$3.03K 0.65% 49
2019
Q2 		$1.08M Sell
163,460
-17,187
-10% -$110K 0.84% 34
2019
Q1 		$1.17M Sell
180,647
-51,034
-22% -$339K 0.95% 31
2018
Q4 		$1.58M Buy
231,681
+18,816
+9% +$109K 1.46% 13
2018
Q3 		$1.41M Sell
212,865
-5,703
-3% -$32K 0.99% 34
2018
Q2 		$1.23M Buy
218,568
+33,279
+18% +$186K 0.87% 40
2018
Q1 		$962K Sell
185,289
-576
-0.3% -$3.08K 0.7% 44
2017
Q4 		$842K Sell
185,865
-6,312
-3% -$35K 0.6% 55
2017
Q3 		$1.21M Buy
192,177
+33,085
+21% +$209K 0.85% 36
2017
Q2 		$975K Buy
159,092
+56,362
+55% +$380K 0.71% 46
2017
Q1 		$754K Buy
+102,730
New +$475K 0.56% 68

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ironwood Investment Management's AUPH Position: Q1 2026 in Review

Ironwood Investment Management reduced its Aurinia Pharmaceuticals (AUPH) stake by 1.4% in Q1 2026, selling an estimated $22.7K and leaving 113,066 shares worth $1.68M. The position accounts for 0.7% of the portfolio, ranked #44.

Ironwood Investment Management first reported a position in AUPH in Q1 2017 and has held it in 37 quarters since. The position peaked at $3.71M in Q3 2021. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Ironwood Investment Management held 113,066 shares of Aurinia Pharmaceuticals worth $1.68M as of Q1 2026.
  • Ironwood Investment Management sold 1,554 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $22.7K.
  • Aurinia Pharmaceuticals made up 0.7% of Ironwood Investment Management's portfolio in Q1 2026, its #44 holding.
  • Ironwood Investment Management first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 37 quarters since.
  • Ironwood Investment Management's Aurinia Pharmaceuticals position peaked at $3.71M in Q3 2021.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Ironwood Investment Management's 13F filing for Q1 2026, filed 15 May 2026.